Business Description
Adynxx Inc
NAICS : 325412
SIC : 2899
ISIN : US0196213096
Description
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -48.24 | |||||
12-1 Month Momentum % | -39.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -1177.61 |
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adynxx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.518 | ||
EPS (TTM) (€) | -2.221 | ||
Beta | 0 | ||
Volatility % | 92.56 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | -39.41 | ||
52-Week Range (€) | 3 - 26.34 | ||
Shares Outstanding (Mil) | 5.81 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Adynxx Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Adynxx Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Adynxx Inc Frequently Asked Questions
What is Adynxx Inc(FRA:HL1C)'s stock price today?
The current price of FRA:HL1C is €3.00. The 52 week high of FRA:HL1C is €26.34 and 52 week low is €3.00.
When is next earnings date of Adynxx Inc(FRA:HL1C)?
The next earnings date of Adynxx Inc(FRA:HL1C) is .
Does Adynxx Inc(FRA:HL1C) pay dividends? If so, how much?
Adynxx Inc(FRA:HL1C) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |